RLYB Financial Statements

Balance sheet, income statement, cash flow, and dividends for Rallybio Corp (RLYB).


$39.83M Market Cap.

As of 03/13/2025 5:00 PM ET (MRY) • Disclaimer

RLYB Market Cap. (MRY)


RLYB Shares Outstanding (MRY)


RLYB Assets (MRY)


Total Assets

$68.11M

Total Liabilities

$6.45M

Total Investments

$51.61M

RLYB Income (MRY)


Revenue

$636.00K

Net Income

-$57.77M

Operating Expense

$61.13M

RLYB Cash Flow (MRY)


CF Operations

-$49.28M

CF Investing

$33.49M

CF Financing

$5.20M

RLYB Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

RLYB Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$68,108,000 (-41.09%)

$115,620,000 (-35.92%)

$180,435,000 (-0.96%)

$182,185,000 (28.43%)

Assets Current

$67,841,000 (-40.90%)

$114,789,000 (-36.05%)

$179,496,000 (-0.76%)

$180,869,000 (28.04%)

Assets Non-Current

$267,000 (-67.87%)

$831,000 (-11.50%)

$939,000 (-28.65%)

$1,316,000 (120.44%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$61,654,000 (-41.94%)

$106,184,000 (-37.29%)

$169,317,000 (-3.58%)

$175,602,000 (29.12%)

Property Plant & Equipment Net

$267,000 (-54.90%)

$592,000 (-34.87%)

$909,000 (77.89%)

$511,000 (78.05%)

Cash & Equivalents

$13,903,000 (-43.24%)

$24,494,000 (-57.00%)

$56,958,000 (-67.51%)

$175,334,000 (25.03%)

Accumulated Other Comprehensive Income

$68,000 (353.33%)

$15,000 (107.01%)

-$214,000 (0%)

$0 (0%)

Deferred Revenue

$1,060,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$51,608,000 (-39.76%)

$85,674,000 (-23.55%)

$112,066,000 (13821.24%)

$805,000 (159.68%)

Investments Current

$51,608,000 (-39.59%)

$85,435,000 (-23.74%)

$112,036,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$239,000 (696.67%)

$30,000 (-96.27%)

$805,000 (159.68%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$278,000 (-71.52%)

$976,000 (-12.39%)

$1,114,000 (84.74%)

$603,000 (-61.81%)

Accumulated Retained Earnings (Deficit)

-$293,020,000 (-24.56%)

-$235,245,000 (-46.40%)

-$160,681,000 (-70.89%)

-$94,027,000 (-100.00%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$154,000 (-60.71%)

$392,000 (-29.37%)

$555,000 (0%)

$0 (0%)

Debt Current

$154,000 (-29.68%)

$219,000 (20.99%)

$181,000 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$173,000 (-53.74%)

$374,000 (0%)

$0 (0%)

Total Liabilities

$6,454,000 (-31.60%)

$9,436,000 (-15.13%)

$11,118,000 (68.89%)

$6,583,000 (12.43%)

Liabilities Current

$6,242,000 (-32.61%)

$9,263,000 (-13.78%)

$10,744,000 (64.01%)

$6,551,000 (12.12%)

Liabilities Non-Current

$212,000 (22.54%)

$173,000 (-53.74%)

$374,000 (1068.75%)

$32,000 (166.67%)

RLYB Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$636,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$19,625,000 (-22.70%)

$25,388,000 (-6.64%)

$27,195,000 (45.13%)

$18,739,000 (144.22%)

Research & Development Expense

$41,507,000 (-22.48%)

$53,544,000 (31.59%)

$40,689,000 (51.21%)

$26,909,000 (52.63%)

Operating Expenses

$61,132,000 (-22.55%)

$78,932,000 (16.27%)

$67,884,000 (48.71%)

$45,648,000 (80.41%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$10,000 (-79.59%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$57,775,000 (22.52%)

-$74,564,000 (-11.87%)

-$66,654,000 (-41.78%)

-$47,013,000 (-77.76%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$57,775,000 (22.52%)

-$74,564,000 (-11.87%)

-$66,654,000 (-41.78%)

-$47,013,000 (-77.76%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$57,775,000 (22.52%)

-$74,564,000 (-11.87%)

-$66,654,000 (-41.78%)

-$47,013,000 (-77.76%)

Weighted Average Shares

$43,544,824 (7.66%)

$40,447,388 (27.11%)

$31,821,311 (24.70%)

$25,519,114 (46.76%)

Weighted Average Shares Diluted

$43,544,824 (7.66%)

$40,447,388 (27.11%)

$31,821,311 (24.70%)

$25,519,114 (46.76%)

Earning Before Interest & Taxes (EBIT)

-$57,775,000 (22.52%)

-$74,564,000 (-11.87%)

-$66,654,000 (-41.81%)

-$47,003,000 (-77.95%)

Gross Profit

$636,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$60,496,000 (23.36%)

-$78,932,000 (-16.27%)

-$67,884,000 (-48.71%)

-$45,648,000 (-80.41%)

RLYB Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$33,492,000 (21.09%)

$27,658,000 (124.66%)

-$112,170,000 (-4707.97%)

-$2,333,000 (-12.60%)

Net Cash Flow from Financing

$5,199,000 (3535.66%)

$143,000 (-99.72%)

$51,078,000 (-38.44%)

$82,967,000 (-42.74%)

Net Cash Flow from Operations

-$49,282,000 (18.22%)

-$60,265,000 (-5.20%)

-$57,284,000 (-25.81%)

-$45,533,000 (-106.60%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$10,591,000 (67.38%)

-$32,464,000 (72.58%)

-$118,376,000 (-437.24%)

$35,101,000 (-70.94%)

Net Cash Flow - Business Acquisitions and Disposals

-$2,000,000 (11.11%)

-$2,250,000 (-650.00%)

-$300,000 (85.00%)

-$2,000,000 (-3.36%)

Net Cash Flow - Investment Acquisitions and Disposals

$35,492,000 (18.62%)

$29,920,000 (126.76%)

-$111,816,000 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

-$12,000 (77.78%)

-$54,000 (83.78%)

-$333,000 (-143.07%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$5,467,000 (1838.65%)

$282,000 (-99.46%)

$51,771,000 (-39.94%)

$86,200,000 (-40.64%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$7,993,000 (-26.80%)

$10,920,000 (14.96%)

$9,499,000 (160.60%)

$3,645,000 (417.76%)

Depreciation Amortization & Accretion

$131,000 (-12.67%)

$150,000 (-10.18%)

$167,000 (53.21%)

$109,000 (75.81%)

RLYB Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00%

-

-

-

Profit Margin

-9084.10%

-

-

-

EBITDA Margin

-9063.50%

-

-

-

Return on Average Equity (ROAE)

-76.60% (-34.62%)

-56.90% (-30.50%)

-43.60% (45.77%)

-80.40% (-75.93%)

Return on Average Assets (ROAA)

-68.20% (-27.72%)

-53.40% (-29.93%)

-41.10% (-36.54%)

-30.10% (7.10%)

Return on Sales (ROS)

-9084.10%

-

-

-

Return on Invested Capital (ROIC)

-101.30% (-39.72%)

-72.50% (0.55%)

-72.90% (-101.81%)

4026.80% (347.82%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.72 (44.42%)

-1.3 (58.68%)

-3.14 (39.36%)

-5.18

Price to Sales Ratio (P/S)

65.73

-

-

-

Price to Book Ratio (P/B)

0.65 (-24.09%)

0.85 (-31.54%)

1.24 (-28.81%)

1.75

Debt to Equity Ratio (D/E)

0.1 (17.98%)

0.09 (34.85%)

0.07 (78.38%)

0.04 (-13.95%)

Earnings Per Share (EPS)

-1.33 (27.72%)

-1.84 (11.96%)

-2.09 (-13.59%)

-1.84 (-21.05%)

Sales Per Share (SPS)

0.01 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.13 (24.03%)

-1.49 (17.31%)

-1.8 (-0.28%)

-1.8 (-40.94%)

Book Value Per Share (BVPS)

1.42 (-46.06%)

2.63 (-50.67%)

5.32 (-22.67%)

6.88 (-12.03%)

Tangible Assets Book Value Per Share (TABVPS)

1.56 (-45.30%)

2.86 (-49.58%)

5.67 (-20.58%)

7.14 (-12.49%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-1 (50.00%)

-2 (33.33%)

-3

Enterprise Value Over EBITDA (EV/EBITDA)

-0.26 (73.39%)

-0.96 (59.87%)

-2.4 (5.96%)

-2.55

Asset Turnover

0.01 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

10.87 (-12.30%)

12.39 (-25.83%)

16.71 (-39.49%)

27.61 (14.20%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$49,282,000 (18.24%)

-$60,277,000 (-5.13%)

-$57,338,000 (-25.01%)

-$45,866,000 (-106.83%)

Enterprise Value (EV)

$14,738,083 (-79.42%)

$71,596,955 (-55.07%)

$159,349,532 (33.30%)

$119,541,914

Earnings Before Tax (EBT)

-$57,775,000 (22.52%)

-$74,564,000 (-11.87%)

-$66,654,000 (-41.78%)

-$47,013,000 (-77.66%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$57,644,000 (22.54%)

-$74,414,000 (-11.92%)

-$66,487,000 (-41.78%)

-$46,894,000 (-77.96%)

Invested Capital

$48,117,000 (-41.50%)

$82,255,000 (-27.39%)

$113,288,000 (37662.67%)

$300,000 (107.11%)

Working Capital

$61,599,000 (-41.63%)

$105,526,000 (-37.47%)

$168,752,000 (-3.19%)

$174,318,000 (28.73%)

Tangible Asset Value

$68,108,000 (-41.09%)

$115,620,000 (-35.92%)

$180,435,000 (-0.96%)

$182,185,000 (28.43%)

Market Capitalization

$39,828,083 (-55.91%)

$90,326,955 (-57.08%)

$210,467,532 (-31.34%)

$306,519,914

Average Equity

$75,411,500 (-42.46%)

$131,054,750 (-14.36%)

$153,036,750 (161.66%)

$58,486,500 (1.08%)

Average Assets

$84,726,250 (-39.34%)

$139,677,000 (-13.92%)

$162,265,250 (3.77%)

$156,374,000 (91.32%)

Invested Capital Average

$57,009,750 (-44.55%)

$102,819,250 (12.51%)

$91,384,500 (7929.04%)

-$1,167,250 (60.26%)

Shares

41,487,586 (9.77%)

37,793,705 (17.98%)

32,034,632 (-0.30%)

32,129,970 (28.52%)